"Leishmania" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A genus of flagellate protozoa comprising several species that are pathogenic for humans. Organisms of this genus have an amastigote and a promastigote stage in their life cycles. As a result of enzymatic studies this single genus has been divided into two subgenera: Leishmania leishmania and Leishmania viannia. Species within the Leishmania leishmania subgenus include: L. aethiopica, L. arabica, L. donovani, L. enrietti, L. gerbilli, L. hertigi, L. infantum, L. major, L. mexicana, and L. tropica. The following species are those that compose the Leishmania viannia subgenus: L. braziliensis, L. guyanensis, L. lainsoni, L. naiffi, and L. shawi.
| Descriptor ID |
D007891
|
| MeSH Number(s) |
B01.268.475.868.488
|
| Concept/Terms |
Leishmania viannia- Leishmania viannia
- Leishmania viannias
- viannias, Leishmania
- Leishmania (Viannia)
- Leishmanias (Viannia)
Leishmania (Leishmania)- Leishmania (Leishmania)
- Leishmanias (Leishmania)
- Leishmania leishmania
- Leishmania leishmanias
- leishmanias, Leishmania
|
Below are MeSH descriptors whose meaning is more general than "Leishmania".
Below are MeSH descriptors whose meaning is more specific than "Leishmania".
This graph shows the total number of publications written about "Leishmania" by people in this website by year, and whether "Leishmania" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 0 | 1 | 1 |
| 2011 | 1 | 0 | 1 |
| 2014 | 0 | 1 | 1 |
| 2019 | 0 | 1 | 1 |
| 2021 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 1 |
| 2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Leishmania" by people in Profiles.
-
Emerging strategies and challenges of molecular therapeutics in antileishmanial drug development. Int Immunopharmacol. 2023 Feb; 115:109649.
-
Chemical Cartography Approaches to Study Trypanosomatid Infection. J Vis Exp. 2022 01 21; (179).
-
Tryp-ing Up Metabolism: Role of Metabolic Adaptations in Kinetoplastid Disease Pathogenesis. Infect Immun. 2021 03 17; 89(4).
-
Drug Resistance in Protozoan Parasites: An Incessant Wrestle for Survival. J Glob Antimicrob Resist. 2019 09; 18:1-11.
-
Determinants of disease phenotype in trypanosomatid parasites. Trends Parasitol. 2014 Jul; 30(7):342-9.
-
Design and development of Amphotericin B bearing polycaprolactone microparticles for macrophage targeting. J Biomed Nanotechnol. 2011 Feb; 7(1):50-1.
-
Evaluation of a rapid immunochromatographic test for diagnosis of kala-azar & post kala-azar dermal leishmaniasis at a tertiary care centre of north India. Indian J Med Res. 2005 Dec; 122(6):485-90.
-
[Cutaneous leishmaniasis in Vienna]. Z Haut Geschlechtskr. 1966 May 15; 40(10):351-4 passim.